Table 2

Correlation between the clinicopathological features and expression of Cripto-1

Cripto-1


Clinicopathological

variables

Cases

(n = 37)

positive (%)

negative (%)

p value


n = 20

n = 17


Gender

0.627

Male

26

14 (53.8)

12 (46.2)

Female

11

6 (54.5)

5 (45.5)

Age(years)a

0.540

≤ 49

21

11(52.4)

10 (47. 6)

>49

16

9 (56.3)

7 (43.7)

Pathological classification(WHO)

0.062

Type I-II

17

12(70.6)

5 (29.4)

Type III

20

8 (40.0)

12 (60.0)

Depth of invasion

T classification

0.474

T1-2

27

14(51.9)

13 (48.1)

T3-4

10

6(60)

4(40)

Lymph node metastasis

N classification

0.034c

N0

9

2 (22.2)

7 (77.8)

N1-3

28

18(64.3)

10 (35.7)

Distant metastasis

0.036c

Yes

5

5(100.0)

0(0.0)

No

32

15 (48.4)

17(51.6)

Clinical Stagingb

0.007c

I-II

15

4 (26.7)

11 (73.3)

III-IV

22

16(72.7)

6(27.3)


agrouping of age was performed according to median.

bclinical staging was performed according to 1992 Fuzhou NPC staging system of China.

c statistical significance (p < 0.05)

Wu et al. BMC Cancer 2009 9:315   doi:10.1186/1471-2407-9-315

Open Data